Trish Connolly. Professor Connolly is a Chartered Engineer with extensive academic and medical industry experience in research, development and commercialisation. She is currently Professor of Bioengineering at the University of Strathclyde in Glasgow as well as CEO of Ohmedics Ltd. She founded the Bioelectronics Research Group at the University of Glasgow in 1988 and from 1992 she was based in the medical industry as Head of Research, Byk Gulden Italia ( Altana Pharma), Milan, Italy, and then Technical Director, Nycomed Amersham, Lausanne, Switzerland 1997-1999 . In 1999 she was appointed to a new Chair in Bioengineering at the University of Strathclyde where she has built a substantial portfolio of medical diagnostics research projects aimed at bringing new and less invasive diagnostic devices to the clinic and to community medicine. From 2003-2007 she advised IVMD LTD as their Chief Science Officer, streamlining their research and development portfolio and four patents were filed from strategic projects pursued in that period. She has a strong interest in strategies for the successful commercialisation of medical device research and in 2006 she founded the Strathclyde Institute of Medical Devices to look after the University’s interests in this sector across the industrial and clinical interfaces. In 2003 she founded the EPSRC Centre for Doctoral Training in Medical Devices and Health Technologies at Strathclyde to train the next generation of leades in Biomedical Engineering.
She has particular awareness of the regulatory needs of new medical products having registered new technology for the FDA and CE mark and has worked on industrialisation projects to take research prototypes from the laboratory to full production. She was elected a Fellow of the Institution of Electrical Engineers (now IET) in 2001, a Fellow of the Royal Society of Edinburgh in 2006 and Fellow of the Royal Society of Medicine in 2007 and Fellow of the Royal Academy of Engineering in 2016.
To Ohmedics she brings her experience and her vision for better, accessible diagnostics and monitoring for patients and citizens to the company strategy. She firmly believes that healthcare understanding and wellbeing is an area that needs expanded for the patient and consumer, with a real need for reasonably priced supportive devices and products for self-management and support in individual health and wellbeing.